9 Israeli startups make CB Insights Top 150 list
Winners were selected by CB Insights’ Intelligence Unit from a pool of over 11,000 digital health companies globally.
Winners were selected by CB Insights’ Intelligence Unit from a pool of over 11,000 digital health companies globally.
Study in mice shows that changing the gut microbiome after smoking cessation prevents the typical weight gain smokers experience after quitting.
Multidisciplinary labs will try to provide a scientific and innovative solutions for specific needs conveyed by partners such as hospitals and schools.
Contestants stop in Jerusalem to model secondhand clothing from Haboydem, a shop that employs women recovering from mental health issues.
Distribution deal will send 20,000 of Illumigyn’s devices across Africa to help detect cervical cancer before it’s too late.
Researchers have developed an immunotherapy platform that inhibits melanoma using TRAIL proteins and NanoGhost technology as a drug-delivery vehicle.
Coalition for Epidemic Preparedness Innovations grant will help establish proof of concept for vaccines protective against existing and new strains.
Measuring Jupiter’s gravity field yields info about the massive storm called the Great Red Spot, and about jet streams that cause the planet’s bands.
Study emphasizes need for strategic conservation and management to safeguard thousands of species that represent millions of years of evolution.
Study finds certain immune cells sometimes ‘switch sides’ and actually help tumors grow; finding has implications for improving immunotherapy
Israeli study also shows 93% effectiveness in preventing the spread of symptomatic infection within seven to 21 days of the second Pfizer dose.
Study suggests the possibility of ‘off-the-shelf’ immunotherapies in which T cell receptors that recognize cancer hotspots can be prepared in advance.
Study done on lab rats suggests empathetic acts are done only for our own peer group to activate the brain’s reward system.
New study shows eosinophils can be summoned to fight cancer by destroying the cancer cells directly and by recruiting T-cells to help.
Hebrew University’s Eliezer Rabinovici will be first Israeli to head the largest nuclear particle research center in the world.